Clincosm LogoSign in Get a demo

recurrent primary peritoneal cavity cancer

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

Suspended
  • Brenner Tumor
  • +27 more
  • metformin hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +9 more
May 16, 2022

Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in

Completed
  • Recurrent Fallopian Tube Cancer
  • +23 more
  • ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 25, 2020

Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in

Completed
  • Recurrent Fallopian Tube Cancer
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 31, 2019

Ovarian Papillary Serous Carcinoma, Ovarian Serous Cystadenocarcinoma, Recurrent Fallopian Tube Cancer Trial in Philadelphia

Withdrawn
  • Ovarian Papillary Serous Carcinoma
  • +5 more
  • metformin hydrochloride
  • +3 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Feb 18, 2019

Male Breast Cancer, Recurrent Breast Cancer, Recurrent Fallopian Tube Cancer Trial in Chicago, Evanston (mifepristone,

Completed
  • Male Breast Cancer
  • +7 more
  • Chicago, Illinois
  • +1 more
Sep 10, 2018

Anxiety Disorder, Depression, Fatigue Trial in Columbus (other, procedure, behavioral)

Completed
  • Anxiety Disorder
  • +19 more
  • questionnaire administration
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 8, 2015

Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Stage IIIA Ovarian Epithelial Cancer Trial in

Completed
Has Results
  • Recurrent Ovarian Epithelial Cancer
  • +9 more
  • Rochester, Minnesota
    Mayo Clinic
May 6, 2014

Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial

Withdrawn
  • Recurrent Fallopian Tube Cancer
  • +32 more
  • ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
  • +3 more
  • (no location specified)
Dec 17, 2013

Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Stage IV Ovarian Epithelial Cancer Trial in Los

Completed
  • Recurrent Ovarian Epithelial Cancer
  • +3 more
  • Los Angeles, California
    University of Southern California
Mar 22, 2013